A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer
Clinical trial NCT02561832 · TERMINATED
Trial details
- NCT number
- NCT02561832
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-06
- Primary completion
- 2016-09-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.